MSB 3.21% $1.13 mesoblast limited

Ann: CEO Presentation to 2023 Annual General Meeting, page-76

  1. 6,922 Posts.
    lightbulb Created with Sketch. 1521
    but it’s not effective in treating all patients suffering from aGVHD. For those patients who are failed by Rux, there are no fda therapies to try.

    The kids just die.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.